Page last updated: 2024-11-07

dehydroepiandrosterone and Low Bone Density

dehydroepiandrosterone has been researched along with Low Bone Density in 4 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Research Excerpts

ExcerptRelevanceReference
"Besides marked bone loss, hypogonadotropic hypogonadism was found in 3 male patients, while normal LH, FSH concentration values were measured in 3 female patients."1.28Is dehydroepiandrosterone-sulphate a possible pathogenetic factor in osteopenia of patients with iron overload? ( Czink, E; Horváth, C; Malek, AA; Siklósi, G, 1991)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Valenti, G1
Denti, L1
Saccò, M1
Ceresini, G1
Bossoni, S1
Giustina, A1
Maugeri, D1
Vigna, GB1
Fellin, R1
Paolisso, G1
Barbagallo, M1
Maggio, M1
Strollo, F1
Bollanti, L1
Romanelli, F1
Latini, M1
Czink, E2
Horváth, C2
Malek, AA2
Siklósi, G2
Turner, RT1
Lifrak, ET1
Beckner, M1
Wakley, GK1
Hannon, KS1
Parker, LN1

Reviews

1 review available for dehydroepiandrosterone and Low Bone Density

ArticleYear
[Calcipenic osteopathy in transfusion hemosiderosis and idiopathic hemochromatosis].
    Orvosi hetilap, 1991, Jun-02, Volume: 132, Issue:22

    Topics: Adult; Bone Diseases, Metabolic; Calcitonin; Calcium; Dehydroepiandrosterone; Female; Hemochromatosi

1991

Other Studies

3 other studies available for dehydroepiandrosterone and Low Bone Density

ArticleYear
Consensus Document on substitution therapy with DHEA in the elderly.
    Aging clinical and experimental research, 2006, Volume: 18, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Aging; Atherosclerosis; Bone Diseases, Metabolic; Cognition Disorder

2006
Is dehydroepiandrosterone-sulphate a possible pathogenetic factor in osteopenia of patients with iron overload?
    Haematologia, 1991, Volume: 24, Issue:1

    Topics: Adult; Bone Density; Bone Diseases, Metabolic; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfat

1991
Dehydroepiandrosterone reduces cancellous bone osteopenia in ovariectomized rats.
    The American journal of physiology, 1990, Volume: 258, Issue:4 Pt 1

    Topics: Animals; Bone and Bones; Bone Diseases, Metabolic; Dehydroepiandrosterone; Delayed-Action Preparatio

1990